Serious Adverse Events Following COVID 19 Vaccination in India: A Retrospective Study

QR Code

Serious Adverse Events Following COVID 19 Vaccination in India: A Retrospective Study

Introduction: The aim of this study was to identify the type and detail the serious adverse events following COVID-19 vaccination in India. Materials and Methods: The descriptive study was conducted by extracting the data from the website by the Ministry of Health and Family Welfare, Government of I...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sruthikrishna Punathukandi, Jayakrishnan Thayyil, Meera S. Nair, Ahana Salam
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-01-01
Series:	Preventive Medicine: Research & Reviews
Subjects:	adverse event following immunisations coronavirus disease 2019 india vaccines
Online Access:	https://journals.lww.com/10.4103/PMRR.PMRR_79_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse Events Following Vaccination: A Review of Russian and International Terminology
by: A. S. Korovkin, et al.
Published: (2024-04-01)

Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic
by: A. A. Zurdinova, et al.
Published: (2022-12-01)

Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior
by: Sujoy Bose, et al.
Published: (2025-07-01)

Assessment of Risk Factors for Non-communicable Diseases among Young Adults in Kerala, India
by: Ahana Salam, et al.
Published: (2024-07-01)

Safety of COVID-19 vaccines
by: B. K. Romanov
Published: (2022-12-01)

Adverse Effects Following Immunisation and Vaccine Hesitancy: A Qualitative Study in a South Indian District
by: Gopalan RB, et al.
Published: (2025-06-01)

Possible Causes of and Measures to Minimise Risks of Abscesses Following DTP Vaccination
by: N. V. Tereshkina, et al.
Published: (2021-03-01)

Need and Rationale of the Adult Immunisation in India: A Review
by: Madhu Gupta, et al.
Published: (2025-03-01)

Adverse Events Following Equine Rabies Immunoglobulin Administration among Category 3 Animal Bite Exposures
by: Jishnu Krishnan, et al.
Published: (2025-05-01)

Monitoring System for Adverse Events Following Immunization in Russia and the World. Modern aspects and problems
by: E. V. Bakhmutskaya, et al.
Published: (2022-11-01)

Suspected adverse events following human papillomavirus vaccination in Ningbo city, 2018-2022: a surveillance data analysis
by: Shaoying ZHOU, et al.
Published: (2025-06-01)

Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection
by: E. V. Zuev, et al.
Published: (2023-10-01)

Adverse events associated with gepants: a pharmacovigilance analysis based on the FDA adverse event reporting system
by: Qi Song, et al.
Published: (2025-06-01)

Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review
by: S. S. Postnikov, et al.
Published: (2025-06-01)

Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023
by: Saleh F. Alqifari, et al.
Published: (2025-07-01)

Strengthening Immunisation Services in India through Digital Transformation from Co-WIN to U-WIN: A Review
by: Sunidhi Karol, et al.
Published: (2024-01-01)

Possible Association Between Concomitant Use of SSRIs with NSAIDs and an Increased Risk of Adverse Events Among People with Depressive Disorders: Data Mining of FDA Adverse Event Reporting System
by: Yi Zhang, et al.
Published: (2025-07-01)

DARE-SAFE: Denominator-Adjusted Rate Estimates of Substance Adverse Events Frequency Evaluation in Pharmaceuticals and Vaccines
by: Matthew Halma, et al.
Published: (2025-03-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

Identifying Predictors of Serious Adverse Events in Antidepressant Treatment from a Decade-Long Nationwide Pharmacovigilance Study: Impact of Dementia and Parkinson’s Disease Treatment
by: Jungmin Han, et al.
Published: (2025-06-01)

Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-05-01)

Neurological adverse events associated with antidepressants: a comprehensive 22-year analysis of the FDA adverse event reporting system
by: Qian Yu, et al.
Published: (2025-08-01)

Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
by: Xinzhen Che, et al.
Published: (2025-06-01)

Serious skin reaction induced by leflunomide in a patient with juvenilechronic arthritis
by: Y V Muravjov, et al.
Published: (2009-02-01)

Correction: Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system
by: Jiazhen Jiang, et al.
Published: (2025-06-01)

Adverse events of modern antifungal drugs during treatment of invasive fungal infections
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Sedation-related Adverse Events Associated with a Diagnostic Upper Endoscopy: A Single Center-observational Study
by: Jihyun Lee, et al.
Published: (2017-12-01)

ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
by: Roop Sharma, et al.
Published: (2025-05-01)

Potential adverse events of fluoxetine: a real-world study based on the FAERS database
by: Xuezheng Gao, et al.
Published: (2025-07-01)

ADVERSE EVENTS OF INTERFERONS WITH SYSTEMIC EFFECT
by: A. A. Toporov, et al.
Published: (2018-02-01)

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System
by: Hang Chen, et al.
Published: (2025-06-01)

Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
by: Behnam Amani, et al.
Published: (2021-12-01)

A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database
by: Chunyue Fang, et al.
Published: (2025-06-01)

Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database
by: Huiling Zhang, et al.
Published: (2025-07-01)

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
by: E. Agostani, et al.
Published: (2025-02-01)

Safety of creatine supplementation: Analysis of Adverse Events reported in clinical trials and adverse event reports
by: Sarah E. Johnson, et al.
Published: (2025-09-01)

Occurrence and predictors of adverse events associated with linezolid in the treatment of patients with drug resistant tuberculosis and their impact on treatment outcomes
by: Abhirami V, et al.
Published: (2025-06-01)

Modern methods of identification of adverse events associated with medication errors
by: A. P. Pereverzev, et al.
Published: (2018-02-01)

Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil
by: Jaqueline Cardena Fernandes, et al.
Published: (2024-09-01)

Post-marketing safety concerns with dolutegravir: a pharmacovigilance study based on the FDA adverse event reporting system database
by: Juan Su, et al.
Published: (2025-07-01)